GSK-3 inhibitor elraglusib enhances tumor-infiltrating immune cell activation in tumor biopsies and synergizes with anti-PD-L1 in a murine model of colorectal cancer

Supporters

Support the authors with ResearchCoin

Tip RSC

Preprint Server

Topics

Biology

Cancer Oncology

Medicine

Immunology

Cancer Research

Show all topics

DOI

10.1101/2023.02.07.527499

License

CC-BY-ND

Other Formats

PDF